These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 26093588)

  • 1. [Guidelines for the use of second-generation long-acting antipsychotics].
    Jarema M; Wichniak A; Dudek D; Samochowiec J; Bieńkowski P; Rybakowski J
    Psychiatr Pol; 2015; 49(2):225-41. PubMed ID: 26093588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second-generation long-acting injectable antipsychotic agents: an overview.
    Drug Ther Bull; 2012 Sep; 50(9):102-5. PubMed ID: 22966099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of long acting injectable atypical antipsychotics: a review.
    De Berardis D; Marini S; Carano A; Lang AP; Cavuto M; Piersanti M; Fornaro M; Perna G; Valchera A; Mazza M; Iasevoli F; Martinotti G; Di Giannantonio M
    Curr Clin Pharmacol; 2013 Aug; 8(3):256-64. PubMed ID: 23343445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness Analysis of Aripiprazole Once-Monthly for the Treatment of Schizophrenia in the UK.
    Tempest M; Sapin C; Beillat M; Robinson P; Treur M
    J Ment Health Policy Econ; 2015 Dec; 18(4):185-200. PubMed ID: 26729007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of arrest in persons with schizophrenia and bipolar disorder in a Florida Medicaid program: the role of atypical antipsychotics, conventional neuroleptics, and routine outpatient behavioral health services.
    Van Dorn RA; Andel R; Boaz TL; Desmarais SL; Chandler K; Becker MA; Howe A
    J Clin Psychiatry; 2011 Apr; 72(4):502-8. PubMed ID: 21527125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia.
    Leucht S; Crippa A; Siafis S; Patel MX; Orsini N; Davis JM
    Am J Psychiatry; 2020 Apr; 177(4):342-353. PubMed ID: 31838873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-month paliperidone palmitate - a new treatment option for schizophrenia.
    Bernardo M; Bioque M
    Expert Rev Clin Pharmacol; 2016 Jul; 9(7):899-904. PubMed ID: 27206330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in atypical antipsychotics for the treatment of schizophrenia: new formulations and new agents.
    Kelleher JP; Centorrino F; Albert MJ; Baldessarini RJ
    CNS Drugs; 2002; 16(4):249-61. PubMed ID: 11945108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffective Psychoses: A Network Meta-Analysis.
    Ostuzzi G; Bertolini F; Del Giovane C; Tedeschi F; Bovo C; Gastaldon C; Nosé M; Ogheri F; Papola D; Purgato M; Turrini G; Correll CU; Barbui C
    Am J Psychiatry; 2021 May; 178(5):424-436. PubMed ID: 33596679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse effects associated with second-generation antipsychotic long-acting injection treatment: a comprehensive systematic review.
    Gentile S
    Pharmacotherapy; 2013 Oct; 33(10):1087-106. PubMed ID: 23776129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study.
    Byerly MJ; Marcus RN; Tran QV; Eudicone JM; Whitehead R; Baker RA
    Schizophr Res; 2009 Feb; 107(2-3):218-22. PubMed ID: 19038534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic effects of paliperidone extended release versus oral olanzapine in patients with schizophrenia: a prospective, randomized, controlled trial.
    Schreiner A; Niehaus D; Shuriquie NA; Aadamsoo K; Korcsog P; Salinas R; Theodoropoulou P; Fernández LG; Uçok A; Tessier C; Bergmans P; Hoeben D
    J Clin Psychopharmacol; 2012 Aug; 32(4):449-57. PubMed ID: 22722501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New second-generation long-acting injectable antipsychotics for the treatment of schizophrenia.
    Citrome L
    Expert Rev Neurother; 2013 Jul; 13(7):767-83. PubMed ID: 23898849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in length of hospital stay and number of hospitalization before and after the administration of three second-generation antipsychotics long-acting injections in patients with schizophrenia: Mirror-image study.
    Suzuki H; Hibino H; Inoue Y; Takaya A
    Asian J Psychiatr; 2018 Apr; 34():43. PubMed ID: 29635221
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazole.
    Potkin SG; Raoufinia A; Mallikaarjun S; Bricmont P; Peters-Strickland T; Kasper W; Baker RA; Eramo A; Sanchez R; McQuade R
    Curr Med Res Opin; 2013 Oct; 29(10):1241-51. PubMed ID: 23822566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paliperidone palmitate versus risperidone long-acting injection in markedly-to-severely ill schizophrenia subjects: onset of efficacy with recommended initiation regimens.
    Fu DJ; Bossie CA; Kern Sliwa J; Ma YW; Alphs L
    Clin Schizophr Relat Psychoses; 2014 Jul; 8(2):101-9, 109A. PubMed ID: 23446197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment continuation of four long-acting antipsychotic medications in the Netherlands and Belgium: A retrospective database study.
    Decuypere F; Sermon J; Geerts P; Denee TR; De Vos C; Malfait B; Lamotte M; Mulder CL
    PLoS One; 2017; 12(6):e0179049. PubMed ID: 28614404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-acting atypical injectable antipsychotics in the treatment of schizophrenia: safety and tolerability review.
    Cañas F; Möller HJ
    Expert Opin Drug Saf; 2010 Sep; 9(5):683-97. PubMed ID: 20690885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment Continuation of 3 Second-Generation Antipsychotic Long-Acting Injections, and Oral Paliperidone in Patients With Schizophrenia for 2 Years.
    Suzuki H; Hibino H; Inoue Y; Takaya A
    J Clin Psychopharmacol; 2018 Dec; 38(6):649-650. PubMed ID: 30334868
    [No Abstract]   [Full Text] [Related]  

  • 20. [Long acting injectable antipsychotics in the treatment of schizophrenia: a review of literature].
    Graffino M; Montemagni C; Mingrone C; Rocca P
    Riv Psichiatr; 2014; 49(3):115-23. PubMed ID: 25000887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.